Based in Cambridge, Massachusetts, ReNAgade Therapeutics was founded in 2021 and focuses on harnessing the potential of RNA therapeutics. They utilize RNA delivery platforms to develop new medications through coding, editing, and gene insertion. Their comprehensive RNA platform allows for an all-RNA system, enabling the production of innovative treatments.